REPLIGEN CORPORATION - COMMON STOCK

Repligen Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Financial Guidance

02 أغسطس 2022 04:30:01 بحسب Nasdaq GlobeNewswire

Repligen to Report Second Quarter 2022 Financial Results

19 يوليو 2022 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors

26 مايو 2022 13:30:00 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at Upcoming Investor Conferences

25 مايو 2022 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Reports First Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance

27 أبريل 2022 04:30:01 بحسب Nasdaq GlobeNewswire

Repligen to Report First Quarter 2022 Financial Results

13 أبريل 2022 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum

18 مارس 2022 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Reports Fourth Quarter and Full Year 2021 Financial Results

17 فبراير 2022 04:30:01 بحسب Nasdaq GlobeNewswire

Repligen Launches AAV Affinity Resins for Gene Therapy Purification

15 فبراير 2022 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at 11th Annual SVB Leerink Healthcare Conference

11 فبراير 2022 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen to Report Fourth Quarter and Full Year 2021 Financial Results

03 فبراير 2022 06:30:09 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at 40th Annual J.P. Morgan Healthcare Conference

30 ديسمبر 2021 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Corporation to Present at Upcoming Investor Conferences

12 نوفمبر 2021 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Releases Inaugural Sustainability Report

05 نوفمبر 2021 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Reports Third Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance

28 أكتوبر 2021 04:30:01 بحسب Nasdaq GlobeNewswire

Repligen to Report Third Quarter 2021 Financial Results

14 أكتوبر 2021 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen Announces Agreement to Acquire Avitide Inc.

16 سبتمبر 2021 04:40:54 بحسب Nasdaq GlobeNewswire

Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies

09 سبتمبر 2021 04:30:01 بحسب Nasdaq GlobeNewswire

Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance

27 يوليو 2021 04:30:00 بحسب Nasdaq GlobeNewswire

Repligen to Report Second Quarter 2021 Financial Results

13 يوليو 2021 04:30:00 بحسب Nasdaq GlobeNewswire